Results for ''
Vaccination is over 90 percent effective at preventing deaths from the Delta variant of Covid-19, according to the first country-level data on mortality. The study was funded by the Medical...
The study used data from the Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II) which was funded by UK Research and Innovation (Medical Research Council); Research and...
In December 2020, the Pfizer-BioNTech and Oxford-AstraZeneca vaccines against COVID-19 were approved for use in the UK. While these vaccines had been thoroughly tested in clinical trials involving...
Are you interested in COVID-19 vaccine safety research? Then join us at our upcoming Data and Connectivity Open Door on COVID-19 vaccine safety research!
Overview As the rollout of first dose COVID-19 vaccines accelerated in the UK and Europe, safety concerns emerged after reports that a small number of people experienced adverse events in their...
New global role builds on success of International COVID-19 Data Alliance (ICODA).
Meta-analysis of association between administration of IL-6 Antagonists and adverse COVID-19 outcomes
Alongside The Alan Turing Institute, we are delighted to launch a new joint funding call as part of the National Core Studies (NCS) into COVID-19.
Health Data Research UK has been working in partnership with data custodians across the UK to make COVID-19 data sets and data linkages available to researchers to inform the pandemic response in...
